Optimising the dosage of ready-to-use therapeutic food in children with uncomplicated severe acute malnutrition in the Democratic Republic of the Congo: a non-inferiority, randomised controlled trialResearch in context

Summary: Background: Current standard management of severe acute malnutrition uses ready-to-use therapeutic food (RUTF) at a single weight-based calculation resulting in an increasing amount of RUTF provided to the family as the child's weight increases during recovery. Using RUTF at a gradual...

Full description

Bibliographic Details
Main Authors: Cécile Cazes, Kevin Phelan, Victoire Hubert, Harouna Boubacar, Liévin Izie Bozama, Gilbert Tshibangu Sakubu, Bruno Bindamba Senge, Norbert Baya, Rodrigue Alitanou, Antoine Kouamé, Cyrille Yao, Delphine Gabillard, Maguy Daures, Augustin Augier, Xavier Anglaret, Moumouni Kinda, Susan Shepherd, Renaud Becquet
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:EClinicalMedicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S258953702300055X
_version_ 1811162658310717440
author Cécile Cazes
Kevin Phelan
Victoire Hubert
Harouna Boubacar
Liévin Izie Bozama
Gilbert Tshibangu Sakubu
Bruno Bindamba Senge
Norbert Baya
Rodrigue Alitanou
Antoine Kouamé
Cyrille Yao
Delphine Gabillard
Maguy Daures
Augustin Augier
Xavier Anglaret
Moumouni Kinda
Susan Shepherd
Renaud Becquet
author_facet Cécile Cazes
Kevin Phelan
Victoire Hubert
Harouna Boubacar
Liévin Izie Bozama
Gilbert Tshibangu Sakubu
Bruno Bindamba Senge
Norbert Baya
Rodrigue Alitanou
Antoine Kouamé
Cyrille Yao
Delphine Gabillard
Maguy Daures
Augustin Augier
Xavier Anglaret
Moumouni Kinda
Susan Shepherd
Renaud Becquet
author_sort Cécile Cazes
collection DOAJ
description Summary: Background: Current standard management of severe acute malnutrition uses ready-to-use therapeutic food (RUTF) at a single weight-based calculation resulting in an increasing amount of RUTF provided to the family as the child's weight increases during recovery. Using RUTF at a gradually reduced dosage as the child recovers could reduce costs while achieving similar growth response. Methods: We conducted an open-label, non-inferiority, randomised controlled trial in the Democratic Republic of the Congo. Children aged 6–59 months with a mid-upper-arm circumference (MUAC) of less than 115 mm or a weight-for-height z-score (WHZ) of less than −3 or bipedal oedema and without medical complication were randomly assigned (1:1 ratio) using a specially developed software and random blocks (size was kept confidential), to either the current standard treatment (increasing the RUTF amount with increasing weight) or the OptiMA strategy (decreasing the RUTF dose with increasing weight and MUAC). The main endpoint was proportion of children who achieved recovery over the 6 months follow up period, as defined as meeting the following criteria for two consecutive weeks after a minimum of 4 weeks' treatment: axillary temperature less than 37.5 °C, no bipedal oedema, and anthropometric improvement (either MUAC 125 mm or greater or WHZ −1.5 or higher). We performed analyses on the intention-to-treat (ITT) (all children) and per-protocol populations (participants who had a minimum prescription of 4 weeks’ RUTF, received at least 90% of the total amount of RUTF they were supposed to receive as per the protocol, and had a maximum interval of 6 weeks between any two visits in the 6-month follow-up). The non-inferiority margin was 10%. This trial is registered at ClinicalTrials.gov, and is now closed NCT03751475. Findings: Between July 22, 2019, and January 20, 2020, 491 children were randomly assigned, of whom 482 were analysed (240 in the standard group and 242 in the OptiMA group). In the ITT analysis, 234 (98%) children in the standard group and 231 (96%) children in OptiMA recovered (difference 2.0%, 95% CI −2.0% to 6.4%). In the PP analysis, 234 (98%) children in the standard group and 228 (97%) in OptiMA recovered (difference 1.3%, 95% CI −2.3% to 5.1%). Sensitivity analyses applying the same anthropometric recovery criteria to each group also showed non-inferiority of the OptiMA strategy in ITT and PP analysis. Interpretation: This non-inferiority trial treating uncomplicated children with MUAC of less than 115 mm or a WHZ of less than −3 or bipedal oedema with decreasing RUTF dose as MUAC and weight increase demonstrated non-inferiority compared to the standard protocol in a highly food-insecure context in the Democratic Republic of the Congo. These findings add evidence on the safety of RUTF dose reduction with significant RUTF cost savings. Funding: Innocent Foundation and European Civil Protection and Humanitarian Aid Operations. Translation: For the French translation of the abstract see Supplementary Materials section.
first_indexed 2024-04-10T06:33:57Z
format Article
id doaj.art-4f09820b0de04a41bb1bb73bb4df3a1b
institution Directory Open Access Journal
issn 2589-5370
language English
last_indexed 2024-04-10T06:33:57Z
publishDate 2023-04-01
publisher Elsevier
record_format Article
series EClinicalMedicine
spelling doaj.art-4f09820b0de04a41bb1bb73bb4df3a1b2023-03-01T04:32:45ZengElsevierEClinicalMedicine2589-53702023-04-0158101878Optimising the dosage of ready-to-use therapeutic food in children with uncomplicated severe acute malnutrition in the Democratic Republic of the Congo: a non-inferiority, randomised controlled trialResearch in contextCécile Cazes0Kevin Phelan1Victoire Hubert2Harouna Boubacar3Liévin Izie Bozama4Gilbert Tshibangu Sakubu5Bruno Bindamba Senge6Norbert Baya7Rodrigue Alitanou8Antoine Kouamé9Cyrille Yao10Delphine Gabillard11Maguy Daures12Augustin Augier13Xavier Anglaret14Moumouni Kinda15Susan Shepherd16Renaud Becquet17National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, University of Bordeaux, Bordeaux, FranceThe Alliance for International Medical Action (ALIMA), Paris, FranceThe Alliance for International Medical Action (ALIMA), Kamuesha, Democratic Republic of the CongoThe Alliance for International Medical Action (ALIMA), Kamuesha, Democratic Republic of the CongoNational Nutrition Programme (PRONANUT), Ministry of Health, Kinshasa, Democratic Republic of the CongoKamuesha Health Zone in the Kasaï Province, Ministry of Health, Kamuesha, Democratic Republic of the CongoNational Nutrition Programme (PRONANUT), Ministry of Health, Kinshasa, Democratic Republic of the CongoNational Nutrition Programme (PRONANUT), Ministry of Health, Kinshasa, Democratic Republic of the CongoThe Alliance for International Medical Action (ALIMA), Kamuesha, Democratic Republic of the CongoPACCI ANRS Research Programme, University Hospital of Treichville, Abidjan, Côte d'IvoirePACCI ANRS Research Programme, University Hospital of Treichville, Abidjan, Côte d'IvoireNational Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, University of Bordeaux, Bordeaux, FranceNational Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, University of Bordeaux, Bordeaux, FranceThe Alliance for International Medical Action (ALIMA), Paris, FranceNational Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, University of Bordeaux, Bordeaux, FranceThe Alliance for International Medical Action (ALIMA), Dakar, SenegalThe Alliance for International Medical Action (ALIMA), Dakar, SenegalNational Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Research Centre, University of Bordeaux, Bordeaux, France; Corresponding author. Bordeaux Population Health Centre, Team GHiGS, University of Bordeaux, Bordeaux 33076, France.Summary: Background: Current standard management of severe acute malnutrition uses ready-to-use therapeutic food (RUTF) at a single weight-based calculation resulting in an increasing amount of RUTF provided to the family as the child's weight increases during recovery. Using RUTF at a gradually reduced dosage as the child recovers could reduce costs while achieving similar growth response. Methods: We conducted an open-label, non-inferiority, randomised controlled trial in the Democratic Republic of the Congo. Children aged 6–59 months with a mid-upper-arm circumference (MUAC) of less than 115 mm or a weight-for-height z-score (WHZ) of less than −3 or bipedal oedema and without medical complication were randomly assigned (1:1 ratio) using a specially developed software and random blocks (size was kept confidential), to either the current standard treatment (increasing the RUTF amount with increasing weight) or the OptiMA strategy (decreasing the RUTF dose with increasing weight and MUAC). The main endpoint was proportion of children who achieved recovery over the 6 months follow up period, as defined as meeting the following criteria for two consecutive weeks after a minimum of 4 weeks' treatment: axillary temperature less than 37.5 °C, no bipedal oedema, and anthropometric improvement (either MUAC 125 mm or greater or WHZ −1.5 or higher). We performed analyses on the intention-to-treat (ITT) (all children) and per-protocol populations (participants who had a minimum prescription of 4 weeks’ RUTF, received at least 90% of the total amount of RUTF they were supposed to receive as per the protocol, and had a maximum interval of 6 weeks between any two visits in the 6-month follow-up). The non-inferiority margin was 10%. This trial is registered at ClinicalTrials.gov, and is now closed NCT03751475. Findings: Between July 22, 2019, and January 20, 2020, 491 children were randomly assigned, of whom 482 were analysed (240 in the standard group and 242 in the OptiMA group). In the ITT analysis, 234 (98%) children in the standard group and 231 (96%) children in OptiMA recovered (difference 2.0%, 95% CI −2.0% to 6.4%). In the PP analysis, 234 (98%) children in the standard group and 228 (97%) in OptiMA recovered (difference 1.3%, 95% CI −2.3% to 5.1%). Sensitivity analyses applying the same anthropometric recovery criteria to each group also showed non-inferiority of the OptiMA strategy in ITT and PP analysis. Interpretation: This non-inferiority trial treating uncomplicated children with MUAC of less than 115 mm or a WHZ of less than −3 or bipedal oedema with decreasing RUTF dose as MUAC and weight increase demonstrated non-inferiority compared to the standard protocol in a highly food-insecure context in the Democratic Republic of the Congo. These findings add evidence on the safety of RUTF dose reduction with significant RUTF cost savings. Funding: Innocent Foundation and European Civil Protection and Humanitarian Aid Operations. Translation: For the French translation of the abstract see Supplementary Materials section.http://www.sciencedirect.com/science/article/pii/S258953702300055XSevere acute malnutritionChildrenReady-to-use therapeutic foodAfricaRandomized clinical trial
spellingShingle Cécile Cazes
Kevin Phelan
Victoire Hubert
Harouna Boubacar
Liévin Izie Bozama
Gilbert Tshibangu Sakubu
Bruno Bindamba Senge
Norbert Baya
Rodrigue Alitanou
Antoine Kouamé
Cyrille Yao
Delphine Gabillard
Maguy Daures
Augustin Augier
Xavier Anglaret
Moumouni Kinda
Susan Shepherd
Renaud Becquet
Optimising the dosage of ready-to-use therapeutic food in children with uncomplicated severe acute malnutrition in the Democratic Republic of the Congo: a non-inferiority, randomised controlled trialResearch in context
EClinicalMedicine
Severe acute malnutrition
Children
Ready-to-use therapeutic food
Africa
Randomized clinical trial
title Optimising the dosage of ready-to-use therapeutic food in children with uncomplicated severe acute malnutrition in the Democratic Republic of the Congo: a non-inferiority, randomised controlled trialResearch in context
title_full Optimising the dosage of ready-to-use therapeutic food in children with uncomplicated severe acute malnutrition in the Democratic Republic of the Congo: a non-inferiority, randomised controlled trialResearch in context
title_fullStr Optimising the dosage of ready-to-use therapeutic food in children with uncomplicated severe acute malnutrition in the Democratic Republic of the Congo: a non-inferiority, randomised controlled trialResearch in context
title_full_unstemmed Optimising the dosage of ready-to-use therapeutic food in children with uncomplicated severe acute malnutrition in the Democratic Republic of the Congo: a non-inferiority, randomised controlled trialResearch in context
title_short Optimising the dosage of ready-to-use therapeutic food in children with uncomplicated severe acute malnutrition in the Democratic Republic of the Congo: a non-inferiority, randomised controlled trialResearch in context
title_sort optimising the dosage of ready to use therapeutic food in children with uncomplicated severe acute malnutrition in the democratic republic of the congo a non inferiority randomised controlled trialresearch in context
topic Severe acute malnutrition
Children
Ready-to-use therapeutic food
Africa
Randomized clinical trial
url http://www.sciencedirect.com/science/article/pii/S258953702300055X
work_keys_str_mv AT cecilecazes optimisingthedosageofreadytousetherapeuticfoodinchildrenwithuncomplicatedsevereacutemalnutritioninthedemocraticrepublicofthecongoanoninferiorityrandomisedcontrolledtrialresearchincontext
AT kevinphelan optimisingthedosageofreadytousetherapeuticfoodinchildrenwithuncomplicatedsevereacutemalnutritioninthedemocraticrepublicofthecongoanoninferiorityrandomisedcontrolledtrialresearchincontext
AT victoirehubert optimisingthedosageofreadytousetherapeuticfoodinchildrenwithuncomplicatedsevereacutemalnutritioninthedemocraticrepublicofthecongoanoninferiorityrandomisedcontrolledtrialresearchincontext
AT harounaboubacar optimisingthedosageofreadytousetherapeuticfoodinchildrenwithuncomplicatedsevereacutemalnutritioninthedemocraticrepublicofthecongoanoninferiorityrandomisedcontrolledtrialresearchincontext
AT lieviniziebozama optimisingthedosageofreadytousetherapeuticfoodinchildrenwithuncomplicatedsevereacutemalnutritioninthedemocraticrepublicofthecongoanoninferiorityrandomisedcontrolledtrialresearchincontext
AT gilberttshibangusakubu optimisingthedosageofreadytousetherapeuticfoodinchildrenwithuncomplicatedsevereacutemalnutritioninthedemocraticrepublicofthecongoanoninferiorityrandomisedcontrolledtrialresearchincontext
AT brunobindambasenge optimisingthedosageofreadytousetherapeuticfoodinchildrenwithuncomplicatedsevereacutemalnutritioninthedemocraticrepublicofthecongoanoninferiorityrandomisedcontrolledtrialresearchincontext
AT norbertbaya optimisingthedosageofreadytousetherapeuticfoodinchildrenwithuncomplicatedsevereacutemalnutritioninthedemocraticrepublicofthecongoanoninferiorityrandomisedcontrolledtrialresearchincontext
AT rodriguealitanou optimisingthedosageofreadytousetherapeuticfoodinchildrenwithuncomplicatedsevereacutemalnutritioninthedemocraticrepublicofthecongoanoninferiorityrandomisedcontrolledtrialresearchincontext
AT antoinekouame optimisingthedosageofreadytousetherapeuticfoodinchildrenwithuncomplicatedsevereacutemalnutritioninthedemocraticrepublicofthecongoanoninferiorityrandomisedcontrolledtrialresearchincontext
AT cyrilleyao optimisingthedosageofreadytousetherapeuticfoodinchildrenwithuncomplicatedsevereacutemalnutritioninthedemocraticrepublicofthecongoanoninferiorityrandomisedcontrolledtrialresearchincontext
AT delphinegabillard optimisingthedosageofreadytousetherapeuticfoodinchildrenwithuncomplicatedsevereacutemalnutritioninthedemocraticrepublicofthecongoanoninferiorityrandomisedcontrolledtrialresearchincontext
AT maguydaures optimisingthedosageofreadytousetherapeuticfoodinchildrenwithuncomplicatedsevereacutemalnutritioninthedemocraticrepublicofthecongoanoninferiorityrandomisedcontrolledtrialresearchincontext
AT augustinaugier optimisingthedosageofreadytousetherapeuticfoodinchildrenwithuncomplicatedsevereacutemalnutritioninthedemocraticrepublicofthecongoanoninferiorityrandomisedcontrolledtrialresearchincontext
AT xavieranglaret optimisingthedosageofreadytousetherapeuticfoodinchildrenwithuncomplicatedsevereacutemalnutritioninthedemocraticrepublicofthecongoanoninferiorityrandomisedcontrolledtrialresearchincontext
AT moumounikinda optimisingthedosageofreadytousetherapeuticfoodinchildrenwithuncomplicatedsevereacutemalnutritioninthedemocraticrepublicofthecongoanoninferiorityrandomisedcontrolledtrialresearchincontext
AT susanshepherd optimisingthedosageofreadytousetherapeuticfoodinchildrenwithuncomplicatedsevereacutemalnutritioninthedemocraticrepublicofthecongoanoninferiorityrandomisedcontrolledtrialresearchincontext
AT renaudbecquet optimisingthedosageofreadytousetherapeuticfoodinchildrenwithuncomplicatedsevereacutemalnutritioninthedemocraticrepublicofthecongoanoninferiorityrandomisedcontrolledtrialresearchincontext